Unbound MEDLINE

A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer. BJU international [BJU Int] Journal article

 
TitleA review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer.
Author(s)Schlegel P 
InstitutionDepartment of Urology, Weill Cornell Medical College, New York, NY 10021, USA. pnschleg@med.cornell.edu
SourceBJU Int 2009 Mar.:7-13.
Languageeng
Pub Type(s)Journal Article
Research Support, Non-U.S. Gov't
PubMed ID19228147
  
Advertise on this site.